As it happens, to find out what is going on in the brain of someone with Alzheimer’s disease, all it takes is a drop of blood. Unimaginable only three years ago, researchers now have plasma biomarkers ...
Despite extensive use of biomarkers in research studies, most Alzheimer’s disease diagnoses in the United States are determined by clinical examination. That may be about to change. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback